Distribution of adipose tissue: Quantification and relationship with hepatic steatosis and vascular profiles of type 2 diabetic patients with metabolic syndrome

Diabetes and Metabolism

Volumn 34, Issue 1, 2008, Pages 68-74

  Illouz, F ^a   Roulier, V ^a,b   Rod, A ^a   Gallois, Y ^a   Pelle C P ^a   Aube C ^a   Rohmer, V ^a   Ritz, P ^a   Ducluzeau, P H ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

Author keywords

Adipose tissue; Metabolic syndrome; MRI; Type 2 diabetes mellitus

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRITIN;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; AUTOANALYSIS; BLOOD VESSEL COMPLIANCE; BODY FAT DISTRIBUTION; CLINICAL ARTICLE; COMMON CAROTID ARTERY; COMPUTER PROGRAM; DIABETIC OBESITY; FATTY LIVER; FEMALE; HUMAN; INTRAABDOMINAL FAT; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK FACTOR; WAIST HIP RATIO;

ADIPOSE TISSUE; ADULT; AGED; BLOOD PRESSURE; BODY SIZE; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA;

EID: 39149142506     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2007.10.007     Document Type: Article

References (29)

1. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., and Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation 109 (2004) 42-46
2. Executive summary of the third report of the National cholesterol education program (NCEP), expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
3. Alberti K.G., Zimmet P., Shaw J., and IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 366 (2005) 1059-1062
4. Boyko E.J., Fujimoto W.Y., Leonetti D.L., and Newell-Morris L. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 23 (2000) 465-471
5. Carr M.C., and Brunzell J.D. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 89 (2004) 2601-2607
6. Alessi M.C., Peiretti F., Morange P., Henry M., Nalbone G., and Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46 (1997) 860-867
7. Lapidus L., Bengtsson C., Larsson B., Pennert K., Rybo E., and Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 289 (1984) 1257-1261
8. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., et al., INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649
9. Abate N., Garg A., Peshock R.M., Stray-Gundersen J., and Grundy S.M. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 96 (1995) 88-98
10. Carr A., Samaras K., Chisholm D.J., and Cooper D.A. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 351 (1998) 1881-1883
11. Abate N., Burns D., Peshock R.M., Garg A., and Grundy S.M. Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res 35 (1994) 1490-1496
12. Shen W., Wang Z., Punyanita M., Lei J., Sinav A., Kral J.G., et al. Adipose tissue quantification by imaging methods: a proposed classification. Obes Res 11 (2003) 5-16
13. Romero-Corral A., Montori V.M., Somers V.K., Korinek J., Thomas R.J., Allison T.G., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006) 666-678
14. Flegal K.M., Graubard B.I., Williamson D.F., and Gail M.H. Excess deaths associated with underweight, overweight, and obesity. JAMA 293 (2005) 1861-1867
15. Franzosi M.G. Should we continue to use BMI as a cardiovascular risk factor?. Lancet 368 (2006) 624-625
16. Ross R., Leger L., Morris D., de Guise J., and Guardo R. Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 72 (1992) 787-795
17. Thomas E.L., and Bell J.D. Influence of undersampling on magnetic resonance imaging measurements of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord 27 (2003) 211-218
18. Gillum R.F. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men - the third national health and nutrition examination survey. Int J Obes Relat Metab Disord 25 (2001) 639-645
19. Iwasaki T., Nakajima A., Yoneda M., Yamada Y., Mukasa K., Fujita K., et al. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care 28 (2005) 2486-2491
20. de Ledinghen V., Ratziu V., Causse X., Bail B.L., Capron D., Renou C., et al., Association francaise pour l'étude du foie (groupe épidemiologie et évaluation). Association nationale des gastroenterologues des hôpitaux generaux de France. Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. J Hepatol 45 (2006) 592-599
21. van Bortel L.M. What does intima-media thickness tell us?. J Hypertens 23 (2005) 37-39
22. Takami R., Takeda N., Hayashi M., Sasaki A., Kawachi S., Yoshino K., et al. Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis. Diabetes Care 24 (2001) 1248-1252
23. Liu K.H., Chan Y.L., Chan W.B., Chan J.C., and Chu C.W. Mesenteric fat thickness is an independent determinant of metabolic syndrome and identifies subjects with increased carotid intima-media thickness. Diabetes Care 29 (2006) 379-384
24. Lihn A.S., Pedersen S.B., and Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 6 (2005) 13-21
25. Farvid M.S., Ng T.W., Chan D.C., Barrett P.H., and Watts G.F. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab 7 (2005) 406-413
26. Shaibi G.Q., Cruz M.L., Weigensberg M.J., Toledo-Corral C.M., Lane C.J., Kelly L.A., et al. Adiponectin independently predicts metabolic syndrome in overweight latino youth. J Clin Endocrinol Metab 92 (2007) 1809-1813
27. Park K.G., Park K.S., Kim M.J., Kim H.S., Suh Y.S., Ahn J.D., et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 63 (2004) 135-142
28. Inoue M., Maehata E., Yano M., Taniyama M., and Suzuki S. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism 54 (2005) 281-286
29. Kotani K., Sakane N., Saiga K., and Kurozawa Y. Leptin: adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima-media thickness. Diabetologia 48 (2005) 2684-2686